Envision Healthcare (EVHC) Q1 Earnings Beat, Revenues Rise
Envision Healthcare Corp. EVHC reported first-quarter earnings of 65 cents per share that beat the Zacks Consensus Estimate by 14%. Earnings were, however, down 5.8% year over year.
Better-than-expected earnings were driven by revenue growth at the company’s Physicians Services segment.
Adjusted EBITDA for the first quarter came at $207.6 million, down 1.3% year over year.
Envision Healthcare Corporation Price, Consensus and EPS Surprise
Envision Healthcare Corporation Price, Consensus and EPS Surprise | Envision Healthcare Corporation Quote
The company reported net revenues of $2.08 billion, which beat the Zacks Consensus Estimate by 2.8% and improved 10.7% year over year.
Total operating expenses of $1.92 billion increased 11.4% year over year, due to higher salaries and benefits and operating cost.
Mixed Segment Performance
Physician Services
Net revenues from the segment were $1.77 billion, reflecting an increase of 13.2% year over year. The revenue growth was driven by 8.2% contribution from acquisitions and 2.7% from same contracts and 2.3% from new contracts.
Adjusted EBITDA was $150.1 million, unchanged year over year.
Ambulatory Services
Net revenues were $307.6 million, down 2.6% year over year, led by weather- and flu-related procedure cancellations.
For the reported quarter, adjusted EBITDA was $57.5 million, down 4.5% year over year.
Financial Update
Envision Healthcare had cash and cash equivalents of $767.4 million, down 1.4% year over year.
At Mar 31, 2018, Envision had total debt outstanding of $4.7 billion. The company’s ratio of total net debt to EBIDTA ratio was 4.2 times at the end of first-quarter 2018.
Net cash provided by operating activities was $37.3 million as of Mar 31, 2018, down from $98.1 million as of Mar 31, 2017.
Second-Quarter 2018 Guidance
The company expects adjusted EPS within the range of 83 cents and 90 cents and adjusted EBITDA in the band of $234-$246 million.
Full-Year 2018 Guidance
The company affirmed its previously provided revenue guidance for 2018, which calls for net revenues in the range of $8.35 billion to $8.53 billion. It, however, pulled up the lower end of the guidance for adjusted EBIDTA and adjusted EPS.
The company expects adjusted EBIDTA of $965 million to $1 billion (versus $960 million to $1 billion) and adjusted EPS between $3.49 and $3.70 (versus $3.46 and $3.70).
Zacks Rank & Other Releases
Envision Healthcare carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among the other firms in the medical sector that have reported fourth-quarter earnings so far, the bottom line at Centene Corp. CNC, Aetna Inc AET and UnitedHealth Group Inc. UNH beat their respective Zacks Consensus Estimate.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Aetna Inc. (AET) : Free Stock Analysis Report
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
Centene Corporation (CNC) : Free Stock Analysis Report
Envision Healthcare Corporation (EVHC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
